Dror Bashan - PRESIDENT AND CEO, Director at Protalix BioTherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
PRESIDENT AND CEO, Director
Issuer Symbol
PLX on NYSE
All Insider Reports
All Insider Reports

Dror Bashan - trading volume in the past year for Protalix BioTherapeutics, Inc.

Holdings reported by Dror Bashan for Protalix BioTherapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2,344,418 $4,430,950 $1.89 19 Dec 2025 By Trust
Common Stock 188,516 $341,213 $1.81 19 Dec 2025 Direct
Stock Option (Right to Buy) 340,000 03 Sep 2025 Direct Common Stock

Transactions reported by Dror Bashan for Protalix BioTherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.